Publications - Page 23 sur 43 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Hypertension pulmonaire (HTP) 31/08/23
Smooth muscle Rac1 contributes to pulmonary hypertension.

Dilasser F, Rio M, Rose L, Tesse A, Guignabert C, Loirand G, Sauzeau V.

Br J Pharmacol. 2022 Jul;179(13):3418-3429.
Hypertension pulmonaire (HTP) 31/08/23
Severe pulmonary hypertension associated with COPD: long-term results of a prospective French multicentre cohort.

Dauriat G, Reynaud-Gaubert M, Cottin V, Lamia B, Montani D, Belhadi D, Humbert M, Laouenan C, Mal H; French group of investigators on severe PH-COPD.

Eur Respir J. 2022 Jul 7;60(1):2102897.
Hypertension pulmonaire (HTP) 31/08/23
Multiparametric evaluation of right ventricular function in pulmonary arterial hypertension associated with congenital heart disease.

Fournier E, Selegny M, Amsallem M, Haddad F, Cohen S, Valdeolmillos E, Le Pavec J, Humbert M, Isorni MA, Azarine A, Sitbon O, Jais X, Savale L, Montani D, Fadel E, Zoghbi J, Belli E, Hascoët S.

Rev Esp Cardiol (Engl Ed). 2022 Aug 6:S1885-5857(22)00209-2.
Hypertension pulmonaire (HTP) 31/08/23
Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells.

Le Vely B, Phan C, Berrebeh N, Thuillet R, Ottaviani M, Chelgham MK, Chaumais MC, Amazit L, Humbert M, Huertas A, Guignabert C, Tu L.

Am J Respir Cell Mol Biol. 2022 Aug;67(2):215-226.
Hypertension pulmonaire (HTP) 31/08/23
Screening for pulmonary veno-occlusive disease in heterozygous EIF2AK4 variant carriers.

Lechartier B, Girerd B, Eyries M, Beurnier A, Humbert M, Montani D.

Eur Respir J. 2022 Aug 18;60(2):2200760.
Hypertension pulmonaire (HTP) 31/08/23
Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE).

Howard LS, Rosenkranz S, Frantz RP, Hemnes AR, Pfister T, Hsu Schmitz SF, Skåra H, Humbert M, Preston IR.

Chest. 2022 Sep 8:S0012-3692(22)03707-2.
Hypertension pulmonaire (HTP) 31/08/23
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation.

Vicaire H, Pavec JL, Mercier O, Montani D, Boucly A, Roche A, Pradère P, Dauriat G, Feuillet S, Pichon J, Jevnikar M, Beurnier A, Jaïs X, Fadel E, Sitbon O, Humbert M, Savale L.

J Heart Lung Transplant. 2022 Sep;41(9):1285-1293.
Hypertension pulmonaire (HTP) 31/08/23
Role of Ion Channels in the Development of Pulmonary Arterial Hypertension.

Antigny F.

Biomolecules. 2022 Sep 25;12(10):1373.
Hypertension pulmonaire (HTP) 31/08/23
Incidental finding of elevated pulmonary arterial pressures during liver transplantation and postoperative pulmonary complications.

Joosten A, Carrier FM, Menioui A, Van der Linden P, Alexander B, Coilly A, Golse N, Allard MA, Lucidi V, Azoulay D, Naili S, Toubal L, Moussa M, Karam L, Pham H, Laukaityte E, Amara Y, Lanteri-Minet M, Samuel D, Sitbon O, Humbert M, Savale L, Duranteau

J. BMC Anesthesiol. 2022 Sep 21;22(1):300.
Hypertension pulmonaire (HTP) 31/08/23
Mineralocorticoid Receptor Antagonism by Finerenone Attenuates Established Pulmonary Hypertension in Rats.

Tu L, Thuillet R, Perrot J, Ottaviani M, Ponsardin E, Kolkhof P, Humbert M, Viengchareun S, Lombès M, Guignabert C.

Hypertension. 2022 Oct;79(10):2262-2273.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

Smooth muscle Rac1 contributes to pulmonary hypertension.

Severe pulmonary hypertension associated with COPD: long-term results of a prospective French multicentre cohort.

Multiparametric evaluation of right ventricular function in pulmonary arterial hypertension associated with congenital heart disease.

Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells.

Screening for pulmonary veno-occlusive disease in heterozygous EIF2AK4 variant carriers.

Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE).

Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation.

Role of Ion Channels in the Development of Pulmonary Arterial Hypertension.

Incidental finding of elevated pulmonary arterial pressures during liver transplantation and postoperative pulmonary complications.

Mineralocorticoid Receptor Antagonism by Finerenone Attenuates Established Pulmonary Hypertension in Rats.